Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Dec 12:11:789.
doi: 10.3332/ecancer.2017.789. eCollection 2017.

Primary non-Hodgkin lymphoma of the prostate: a case report

Affiliations
Free PMC article
Case Reports

Primary non-Hodgkin lymphoma of the prostate: a case report

Oscar D Martín et al. Ecancermedicalscience. .
Free PMC article

Abstract

This report is of a 68-year-old male patient with a three-year history of severe, progressive, low urinary tract symptoms (LUTS) with a score of 20 points on the International Symptom Scale. The patient received alpha-1-blocker therapy without adequate response. Transurethral resection of the prostate was performed, and the anatomopathological report indicated the presence of a haematolymphoid small-cell neoplasia and glandulostromal prostatic hyperplasia. Posterior immunohistochemistry evaluation reported an extra-nodal marginal zone-B lymphoma non-Hodgkin lymphoma. The patient was followed up for five years by the urology and oncology departments. In the fourth year of follow-up, the patient had B symptoms (fever, night sweats and weight loss). At the same time, laboratory tests showed haemolytic anaemia; then a new bone marrow biopsy was carried out. The histopathological specimen showed six lymphoid aggregates, constituted by a B-cell population with intra-trabecular predominance and reactivity for CD20 and BCL-2. New thoracic and abdominal computed tomographies were performed without any findings suggestive of extra-prostatic spreading. Subsequently, a chemotherapy regimen was started on the patient with the following therapeutic scheme: Rituximab 375 mg/m2 IV per day, cyclophosphamide 750 mg/m2 IV per day, Vincristine 1.4 mg/m2 IV dose per day and Prednisone 40 mg/m2 on days 1-5 (R-CVP scheme) for 21 days, until he completed six cycles. No signs, symptoms or progression have been recorded.

Keywords: extra-nodal marginal zone-B lymphoma; non-Hodgkin lymphoma; prostate.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. The anatomopathological report showed suspicion of compromise for small-cell neoplasia of possible haematolymphoid strain. Bone marrow cylinders with 60% megakaryocytes cellularity and with presence and evidence of all cell lines. Aggregates of mature lymphocytes of interstitial distribution are indicated by a black arrow.
Figure 2.
Figure 2.. Bone marrow biopsy. Well-differentiated lymphocytic haematolymphoid neoplasm. Flowcytometry does not show infiltration by haematolymphoid neoplasm.

Similar articles

Cited by

References

    1. Kandel LB, McCullough DL, Harrison LH, et al. Primary renal lymphoma. Does it exist? Cancer. 1987;60:386–391. - PubMed
    1. Patel DR, Gomez GA, Henderson ES, et al. Primary prostatic involvement in non-Hodgkin lymphoma. Urology. 1988;32(2):96–98. doi: 10.1016/0090-4295(88)90305-6. - DOI - PubMed
    1. Amat Cecilia M, Romero Perez P, Sevilla Chica FI. Lymphomas of the urogenital system. Review of the entirety and report of 2 cases with testicular localization. Arch Esp Urol. 1994;47(10):992–997. - PubMed
    1. Horii SC, Bosniak MA, Megibow AJ, et al. Correlation of CT and ultrasound in the evaluation of renal lymphoma. Urol Radiol. 1983;5(2):69–76. doi: 10.1007/BF02926774. - DOI - PubMed
    1. Vesa Llanes J, Bielsa Gali O, Llado Carbonell C, et al. Bladder involvement in non-Hodgkin’s lymphoma. Diagnosis and therapeutic response. Actas Urol Esp. 1992;16(2):162–165. - PubMed

Publication types

LinkOut - more resources